Table 3 Treatment and outcomes
Variables | Malaria-PCR positive | Malaria-PCR negative | P value* |
|---|---|---|---|
In-hospital treatment | |||
Blood transfusion (%) | 89/130 (68.5%) | 64/159 (40.3%) | < 0.001 |
Oxygen treatment (%) | 116/135 (85.9%) | 140/163 (85.9%) | 0.99 |
Malaria treatment (%) | 135/139 (97.1%) | 146/160 (91.3%) | 0.03 |
Quinine treatment (%) | 75/137 (54.7%) | 101/161 (62.7%) | 0.16 |
Anti-convulsives (%) | 77/127 (60.6%) | 115/156 (73.7%) | 0.02 |
Antibiotics (%) | 86/132 (65.2%) | 134/160 (83.8%) | < 0.001 |
Corticosteroids (%) | 7/121 (5.8%) | 36/155 (23.2%) | < 0.001 |
Acyclovir (%) | 6/121 (5.0%) | 32/155 (20.6%) | < 0.001 |
TB treatment (%) | 0/136 (0.0%) | 13/168 (7.7%) | < 0.001 |
Length of hospitalization, median days (IQR) | 6 (4–9) | 8 (5–13) | < 0.001 |
Disease outcomes | |||
Death | 37/148 (25%) | 54/171 (31.6%) | 0.19 |
Day of death, median (IQR) | 3 (2–4) | 5 (3–9) | < 0.001 |
SeNeSe at discharge | 3/102 (2.9%) | 17/104 (16.3%) | 0.001 |
AnNeSe at discharge | 5/97 (5.2%) | 30/102 (29.4%) | < 0.001 |
Death or SeNeSe | 40/139 (28.8%) | 71/158 (44.9%) | 0.004 |